Letter to the editorALK-fusion-positive secondary ameloblastic carcinoma reached complete response after using alectinib
Section snippets
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References (4)
- et al.
Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population
Int J Oral Maxillofac Surg
(2007) - et al.
Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma
Chin J Cancer Res
(2017)
There are more references available in the full text version of this article.
Cited by (1)
© 2022 Elsevier Ltd. All rights reserved.